SONNET BIOTHERAPEUTICS HOLDI (SONN)
US83548R3030 - Common Stock
| MRQ (2023-12-31) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | 2020 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 3.02M | 2.27M | 3.05M | 27.62M | 500.00K | |||
| Receivables | 194.11K | 786.57K | N/A | N/A | 130.00K | |||
| Inventories | N/A | N/A | N/A | N/A | 290.00K | |||
| Other Current Assets | 1.41M | 1.68M | 2.36M | 1.19M | 250.00K | |||
| Total Current Assets | 4.62M | 4.74M | 5.41M | 28.81M | 1.17M | |||
| Non-Current Assets | ||||||||
| PPE Net | 207.08K | 227.06K | 300.00K | 180.00K | 17.30M | |||
| Investments And Advances | N/A | N/A | N/A | N/A | 690.00K | |||
| Goodwill | N/A | N/A | N/A | N/A | 8.57M | |||
| Intangibles | N/A | N/A | N/A | N/A | 3.66M | |||
| Other Non-Current Assets | 506.86K | 464.19K | 110.00K | 0.00 | 150.00K | |||
| Total Non-Current Assets | 713.95K | 691.25K | 420.00K | 180.00K | 30.36M | |||
| TOTAL ASSETS | 5.34M | 5.43M | 5.83M | 28.99M | 31.53M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | 6.63M | |||
| Accrued Expenses | 998.92K | 3.30M | 3.25M | 2.40M | 7.24M | |||
| Accounts Payable | 1.66M | 2.20M | 4.75M | 3.78M | 4.23M | |||
| Other Current Liabilities | 0.00 | 18.63K | 170.00K | 520.00K | 0.00 | |||
| Total Current Liabilities | 2.65M | 5.52M | 8.16M | 6.70M | 18.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 710.00K | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | 100.00K | |||
| Other Non-Current Liabilities | 110.96K | 130.86K | 200.00K | 30.00K | 15.78M | |||
| Total Non-Current Liabilities | 110.96K | 130.86K | 210.00K | 30.00K | 17.04M | |||
| TOTAL LIABILITIES | 2.77M | 5.66M | 8.37M | 6.73M | 35.14M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -111.41M | -110.24M | -91.41M | -61.69M | -75.07M | |||
| Additional Paid In Capital | 113.98M | 110.02M | 88.87M | 83.94M | 71.51M | |||
| Minority Interest | N/A | N/A | N/A | N/A | 860.00K | |||
| Common Shares | 310.00 | 180.00 | 0.00 | 10.00K | 0.00 | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | -50.00K | |||
| Shares Outstanding | 3.07M | 1.75M | 250.00K | 200.00K | 0.00 | |||
| Tangible Book Value per Share | 0.84 | -0.13 | -10.16 | 111.30 | 60.40 | |||
| Total Shareholders' Equity | 2.57M | -225.98K | -2.54M | 22.26M | -3.61M | |||
| TOTAL LIABILITIES AND EQUITY | 5.34M | 5.43M | 5.83M | 28.99M | 31.53M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | -0.20 | |||
| Current Ratio | 1.74 | 0.86 | 0.66 | 4.30 | 0.06 | |||
| Return On Assets (ROA) | -271.00% | -346.86% | -509.78% | -86.17% | -56.58% | |||
| Return On Equity (ROE) | -562.31% | N/A | N/A | -112.22% | N/A | |||
All data in USD